EdgarLookup

Acrivon Therapeutics, Inc. — EFFECT Filings

3 EFFECT filings on record

This page lists all EFFECT filings submitted to the SEC by Acrivon Therapeutics, Inc. (ACRV), sorted by most recent first. Each row links to the full filing on EdgarLookup. Acrivon Therapeutics, Inc. has filed 3 EFFECT documents with the SEC since 2021. To view all SEC filings by Acrivon Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 3/A 4 424B4 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DEFR14A DRS DRS/A DRSLTR EFFECT FWP S-1 S-1/A S-1MEF S-3 S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
EFFECT — 9999999995-24-001188 Apr 29, 2024 —
EFFECT — 9999999995-23-003657 Dec 15, 2023 —
EFFECT — 9999999995-22-003246 Nov 9, 2022 —